EMPLOYMENT AGREEMENTEmployment Agreement • March 14th, 2016 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • California
This Employment Agreement (“Agreement”) is made as of the 25th day of January, 2016, between Anthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Klara Dickinson-Eason (the “Executive”).
ANTHERA PHARMACEUTICALS, INC. Deferred Compensation Election FormDeferred Compensation Agreement • March 14th, 2016 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations
As specified below, I elect pursuant to the Deferred Compensation Agreement entered into by Anthera Pharmaceuticals, Inc. (the “Company”) and me as of the 28th day of December, 2015 (the “Deferred Compensation Agreement”) to defer receipt of that percentage of my Eligible Compensation which would otherwise be paid to me for services during 2016 (with respect to compensation earned with respect to services to be performed by me subsequent to the date of this election) and subsequent calendar years:
SUBSCRIPTION AGREEMENTSubscription Agreement • March 14th, 2016 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Subscription Agreement (this “Subscription”) is dated August 14, 2015, by and between the investor identified on the signature page hereto (the “Investor”) and Anthera Pharmaceuticals, Inc., a company incorporated and registered in the State of Delaware (the “Company”). The Investor and the Company are parties to a Stock Purchase Agreement dated December 11, 2014 (the “Stock Purchase Agreement”) pursuant to which the Company has the right to direct the Investor to purchase registered shares of the Company’s common stock, $0.001 par value per share, on the terms specified in the Stock Purchase Agreement, by delivering notice to the Investor. Purchases of shares pursuant to the Stock Purchase Agreement are partial consideration for rights granted by the Company to the Investor under the parties’ Collaboration and License Agreement dated December 11, 2014 (the “License Agreement”). The Company delivered to the Investor the Second Closing Notice (as such term is defined in the Stock P
